Published in Gynecol Oncol on July 01, 2001
Clinical characteristics of metastatic tumors to the ovaries. J Korean Med Sci (2009) 1.02
Surgical treatment for patients with Krukenberg tumor of stomach origin: clinical outcome and prognostic factors analysis. PLoS One (2013) 0.98
Metachronous ovarian metastases following resection of the primary gastric cancer. J Gastric Cancer (2011) 0.97
Breast metastatic localization of signet-ring cell gastric carcinoma. ISRN Obstet Gynecol (2010) 0.96
Krukenberg tumor: a rare cause of ovarian torsion. J Clin Imaging Sci (2012) 0.92
Pathways of metastases from primary organs to the ovaries. Obstet Gynecol Int (2011) 0.91
Surgical treatment of recurrent gastric cancer. Gastric Cancer (2008) 0.89
Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor. Cancer Res Treat (2014) 0.84
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience. World J Surg (2016) 0.78
Krukenberg tumour arising from adenocarcinoma of the gastro-oesophageal junction in a 28-year-old female presenting as lower abdominal swelling mimicking an inguinal hernia. BMJ Case Rep (2011) 0.78
Appendiceal mixed adenoneuroendocrine carcinomas, a rare entity that can present as a Krukenberg tumor: case report and review of the literature. World J Surg Oncol (2015) 0.78
A case of virilization induced by a Krukenberg tumor from gastric cancer. World J Surg Oncol (2008) 0.76
Dyspnoea and the ovaries: a rare presentation of Krukenberg tumour. BMJ Case Rep (2013) 0.76
Clinical characteristics and prognostic analysis of Krukenberg tumor. Mol Clin Oncol (2015) 0.75
Exophthalmos Revealing a Krukenberg Tumor: A Case Presentation and Review of the Literature. Case Rep Oncol (2016) 0.75
Clinical analysis of Krukenberg tumours in patients with colorectal cancer-a review of 57 cases. World J Surg Oncol (2017) 0.75
Metastatic gastric cancer to the female genital tract. Mol Clin Oncol (2016) 0.75
F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin. J Cancer Res Clin Oncol (2015) 0.75
Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci U S A (1994) 1.87
Analysis of errors in medical rapid prototyping models. Int J Oral Maxillofac Surg (2002) 1.76
Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res (2004) 1.71
Clipping vs coiling of posterior communicating artery aneurysms with third nerve palsy. Neurology (2006) 1.64
Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2. Gastroenterology (1990) 1.63
Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb Res (2003) 1.51
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer. Ann Oncol (2002) 1.50
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol (2007) 1.50
Robotic tumor-specific mesorectal excision of rectal cancer: short-term outcome of a pilot randomized trial. Surg Endosc (2008) 1.46
Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis. Cytokine Growth Factor Rev (2000) 1.45
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer (2008) 1.41
Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer. Ann Oncol (2003) 1.27
Loss of TGF-beta signaling contributes to autoimmune pancreatitis. J Clin Invest (2000) 1.18
Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions. Clin Exp Dermatol (2001) 1.17
Evaluation of bone metastases by Tc-99m MDP imaging in patients with stomach cancer. Clin Nucl Med (1995) 1.16
Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer. Oncogene (1999) 1.16
Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer (1997) 1.16
Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells. Cancer Res (2001) 1.15
Three cases of fistulae arising from gastrointestinal tract treated with endoscopic injection of Histoacryl. Endoscopy (2001) 1.15
Tailgut cyst: multilocular cystic appearance on MRI. J Comput Assist Tomogr (1997) 1.14
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. Hum Gene Ther (2001) 1.09
Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol (2008) 1.08
Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma. Cancer (1999) 1.08
Frameshift mutations at coding mononucleotide repeats of the hRAD50 gene in gastrointestinal carcinomas with microsatellite instability. Cancer Res (2001) 1.07
Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron. J Int Med Res (2002) 1.05
A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor. J Biol Chem (1998) 1.05
Germline mutations of the STK11 gene in Korean Peutz-Jeghers syndrome patients. Br J Cancer (2000) 1.05
Alterations of p16INK4A and p15INK4B genes in gastric carcinomas. Cancer (1997) 1.04
Clinical characteristics of Peutz-Jeghers syndrome in Korean polyposis patients. Int J Colorectal Dis (2000) 1.02
CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients. Br J Cancer (2011) 1.00
Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma. Ann Oncol (2009) 1.00
The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol (2012) 0.99
Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability. Pathol Res Pract (1998) 0.99
Value of alkaline phosphatase, 5'-nucleotidase, gamma-glutamyltransferase, and glutamate dehydrogenase activity measurements (single and combined) in serum in diagnosis of metastasis to the liver. Clin Chem (1977) 0.99
Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma. Ann Oncol (2009) 0.99
Advanced hypopharyngeal carcinoma treatment results according to treatment modalities. Head Neck (2001) 0.97
Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma. Ann Oncol (2009) 0.96
Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by dna hypermethylation of the 5'-CpG island in human gastric cancer cell lines. Int J Cancer (2000) 0.95
Development of terminal cancer prognostic score as an index in terminally ill cancer patients. Oncol Rep (2001) 0.94
Antibiotic use during the last days of life in cancer patients. Eur J Cancer Care (Engl) (2006) 0.93
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer. Ann Oncol (2007) 0.92
P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J Clin Invest (1992) 0.92
Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma. Int J Cancer (2000) 0.92
Incidence estimation of stomach cancer among Koreans. J Korean Med Sci (1991) 0.92
Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells. Oncogene (2001) 0.92
Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ. Cancer Res (1992) 0.92
Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res (1997) 0.91
Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results. Ann Oncol (2010) 0.91
Targeted RNA interference of phosphatidylinositol 3-kinase p110-beta induces apoptosis and proliferation arrest in endometrial carcinoma cells. J Pathol (2007) 0.91
Predictors of prescription of morphine for severe cancer pain by physicians in Korea. Ann Oncol (2005) 0.91
CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface. J Immunol (2001) 0.91
Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma. Cancer (1999) 0.90
Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma. Br J Cancer (2008) 0.90
Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression. Anticancer Res (1998) 0.90
Effect of fiber type on postmortem proteolysis in longissimus muscle of Landrace and Korean native black pigs. Meat Sci (2007) 0.90
Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2). Blood (1998) 0.90
Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta. Int J Cancer (1998) 0.90
Impact of perception of socioeconomic burden on advocacy for patient autonomy in end-of-life decision making: a study of societal attitudes. Palliat Med (2008) 0.90
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone. Ann Oncol (2008) 0.89
Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma. Ann Oncol (2007) 0.89
Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer (1999) 0.88
Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) . Cancer Chemother Pharmacol (1998) 0.87
Detection of Epstein-Barr virus in Korean peripheral T-cell lymphoma. Am J Hematol (1999) 0.86
Enhancement of adenoviral transduction with polycationic liposomes in vivo. Cancer Gene Ther (2000) 0.86
Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study. Ann Oncol (2007) 0.86
Preclinical and phase I clinical studies with Ckd-602, a novel camptothecin derivative. Ann N Y Acad Sci (2000) 0.85
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives. Br J Cancer (2008) 0.85
Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer. Eur J Surg Oncol (2001) 0.85
Three phenotypes of obstructive lung disease in the elderly. Int J Tuberc Lung Dis (2010) 0.85